Uniphos Enterprises Limited
NSE: UNIENTER · Trading - Chemicals
Snapshot
Unlock Uniphos Enterprises Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Uniphos Enterprises Limited is primarily engaged in the trading of chemicals and various other products. Additionally, the company maintains a portfolio of investments in both quoted and unquoted securities.
Business Model
The company generates revenue through the commercial trading of chemical products and by managing a diversified investment portfolio. It operates as a subsidiary of Nerka Chemicals Private Limited.
Growth Outlook
Growth is primarily dependent on the volatility of chemical commodity prices and the performance of the company's underlying investment holdings.
Key Risks
- Market Volatility. Fluctuations in global chemical prices can significantly impact trading margins and profitability.
- Investment Risk. The value of the company's quoted and unquoted securities is subject to market risks and the financial health of the investee entities.
- Supply Chain Disruptions. As a trading entity, the company is vulnerable to logistical bottlenecks and supply disruptions within the chemical sector.
- Regulatory Risk. Changes in environmental regulations or trade policies regarding chemicals could adversely affect business operations.
Start your research today
Unlock AI insights, financials, peers and live data on Uniphos Enterprises Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹26 Cr
TTM · standalone
NET PROFIT
₹24 Cr
TTM · standalone
EPS
₹3.41
TTM · standalone
RETURN ON EQUITY
0.9%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
0.9%
TTM · standalone
P/E
25.5×
Q1 FY27 · standalone
EV/EBITDA
25.5x
Q1 FY27 · standalone
EBITDA MARGIN
92.7%
TTM · standalone
NET PROFIT MARGIN
2.7%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Trading - Chemicals
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Uniphos Enterprises LimitedUNIENTER | ₹633 Cr | 25.5× | 25.51 | -77.1% | 92.7% | 0.9% | 0.9% | -41.6% |
Vinyl Chemicals (India) LimitedVINYLINDIA | ₹406 Cr | 21.0× | 16.00 | -3.2% | 4.2% | 14.5% | 19.4% | -24.5% |
A-1 LimitedA1L | ₹287 Cr | 23.8× | 19.80 | 38.7% | 3.7% | 16.5% | 26.0% | -99.4% |
As of Q1 FY27
Financials
Uniphos Enterprises Limited
NSE: UNIENTER · Trading - Chemicals
Snapshot
Unlock Uniphos Enterprises Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Uniphos Enterprises Limited is primarily engaged in the trading of chemicals and various other products. Additionally, the company maintains a portfolio of investments in both quoted and unquoted securities.
Business Model
The company generates revenue through the commercial trading of chemical products and by managing a diversified investment portfolio. It operates as a subsidiary of Nerka Chemicals Private Limited.
Growth Outlook
Growth is primarily dependent on the volatility of chemical commodity prices and the performance of the company's underlying investment holdings.
Key Risks
- Market Volatility. Fluctuations in global chemical prices can significantly impact trading margins and profitability.
- Investment Risk. The value of the company's quoted and unquoted securities is subject to market risks and the financial health of the investee entities.
- Supply Chain Disruptions. As a trading entity, the company is vulnerable to logistical bottlenecks and supply disruptions within the chemical sector.
- Regulatory Risk. Changes in environmental regulations or trade policies regarding chemicals could adversely affect business operations.
Start your research today
Unlock AI insights, financials, peers and live data on Uniphos Enterprises Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹26 Cr
TTM · standalone
NET PROFIT
₹24 Cr
TTM · standalone
EPS
₹3.41
TTM · standalone
RETURN ON EQUITY
0.9%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
0.9%
TTM · standalone
P/E
25.5x
Q1 FY27 · standalone
EV/EBITDA
25.5x
Q1 FY27 · standalone
EBITDA MARGIN
92.7%
TTM · standalone
NET PROFIT MARGIN
2.7%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Trading - Chemicals
As of Q1 FY27